Her scientific interests lie mostly in Immunology, Hemophagocytic lymphohistiocytosis, Internal medicine, Transplantation and Gastroenterology. The various areas that Alexandra H. Filipovich examines in her Immunology study include Cytotoxic T cell and Eosinophilic esophagitis. Her Hemophagocytic lymphohistiocytosis research incorporates themes from Alemtuzumab, Pediatrics, Familial Hemophagocytic Lymphohistiocytosis and Intensive care medicine.
Her study looks at the intersection of Internal medicine and topics like Oncology with Long term results. Her Transplantation research incorporates elements of Leukemia and Severe combined immunodeficiency. Alexandra H. Filipovich studied Gastroenterology and Surgery that intersect with Cerebrospinal fluid and Meningoencephalitis.
Alexandra H. Filipovich mostly deals with Immunology, Internal medicine, Transplantation, Hemophagocytic lymphohistiocytosis and Hematopoietic stem cell transplantation. Her biological study deals with issues like Cytotoxic T cell, which deal with fields such as CD8. Alexandra H. Filipovich has researched Internal medicine in several fields, including Gastroenterology, Surgery and Oncology.
Her Transplantation study incorporates themes from Hematopoietic cell, Regimen, Stem cell and Bone marrow. Her research investigates the connection between Hemophagocytic lymphohistiocytosis and topics such as Familial Hemophagocytic Lymphohistiocytosis that intersect with problems in UNC13D and Hepatosplenomegaly. In her work, Newborn screening and Genetic enhancement is strongly intertwined with Severe combined immunodeficiency, which is a subfield of Hematopoietic stem cell transplantation.
Her main research concerns Immunology, Internal medicine, Hematopoietic stem cell transplantation, Transplantation and Hemophagocytic lymphohistiocytosis. The study of Immunology is intertwined with the study of Treatment outcome in a number of ways. Her biological study spans a wide range of topics, including Gastroenterology and Oncology.
Her Hematopoietic stem cell transplantation study is concerned with the larger field of Surgery. Her Transplantation research integrates issues from Hematopoietic cell, Immunodeficiency, Young adult, MECOM and Stem cell. Her Hemophagocytic lymphohistiocytosis research includes themes of Dermatology, Cytotoxic T cell and Familial Hemophagocytic Lymphohistiocytosis.
Alexandra H. Filipovich spends much of her time researching Immunology, Transplantation, Internal medicine, Hematopoietic stem cell transplantation and Hemophagocytic lymphohistiocytosis. Her Immunology research focuses on Familial Hemophagocytic Lymphohistiocytosis, Immune system, Immune receptor, Abatacept and Immune dysregulation. Alexandra H. Filipovich usually deals with Transplantation and limits it to topics linked to Severe combined immunodeficiency and Natural history and Virology.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Surgery and Oncology. Her Hematopoietic stem cell transplantation study integrates concerns from other disciplines, such as Infectious disease, Transplantation Conditioning, Pediatrics and Immunodeficiency. Her Hemophagocytic lymphohistiocytosis research is multidisciplinary, incorporating perspectives in Cytotoxic T cell, Pathogenesis, Treatment outcome, Interleukin and UNC13D.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
Jan-Inge Henter;Annacarin Horne;Maurizio Aricó;R Maarten Egeler.
Pediatric Blood & Cancer (2007)
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Vanderson Rocha;Jacqueline Cornish;Eric L. Sievers;Alexandra Filipovich.
How I treat hemophagocytic lymphohistiocytosis
Michael B. Jordan;Carl E. Allen;Sheila Weitzman;Alexandra H. Filipovich.
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Neal Flomenberg;Lee Ann Baxter-Lowe;Dennis Confer;Marcelo Fernandez-Vina.
Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.
Jan-Inge Henter;AnnaCarin Samuelsson-Horne;Maurizio Aricò;R Maarten Egeler.
ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency
Andrew C. Chan;Theresa A. Kadlecek;Melissa E. Elder;Alexandra H. Filipovich.
Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009
Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley.
The New England Journal of Medicine (2014)
HLH‐94: A treatment protocol for hemophagocytic lymphohistiocytosis
J I Henter;M Aricò;R M Egeler;G Elinder.
Medical and Pediatric Oncology (1997)
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.
Helena Trottestam;AnnaCarin Horne;Maurizio Arico;R. Maarten Egeler.
Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice
Eliane Gluckman;Vanderson Rocha;William Arcese;Gérard Michel.
Experimental Hematology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: